MGI and Nanodigmbio Announce Partnership for High-Quality Targeted Sequencing
Shanghai, China, December 25, 2018 – MGI, a subsidiary of BGI and Shanghai Nanodigmbio Biotechnology Co., Ltd. ("Nanodigmbio") have signed a strategic cooperation agreement focusing on high-quality targeted sequencing during the Sequencing Summit China 2018. The two sides will jointly develop library preparation and target capture package based on MGI's sequencing platforms. The signing of this cooperation agreement will promote the use of self-developed equipment, creating a brand-new industri...
More2018-12-27